relative bioavailability

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relative Bioavailability Trial (PanCytoVir™)

Not yet recruiting
  • Relative Bioavailability
  • (no location specified)
Sep 5, 2023

Relative Bioavailability Trial (PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg)

Not yet recruiting
  • Relative Bioavailability
  • PanCytoVir™ 100 mg/mL oral suspension
  • Probenecid 500 mg
  • (no location specified)
Sep 5, 2023

Relative Bioavailability Trial in Hartford (Tebipenem tablet form, Tube feeds)

Active, not recruiting
  • Relative Bioavailability
  • Tebipenem tablet form
  • Tube feeds
  • Hartford, Connecticut
    Hartford Hospital
Aug 26, 2022

Relative Bioavailability Trial in Randwick (BLD-0409)

Completed
  • Relative Bioavailability
  • Randwick, New South Wales, Australia
    Scientia Clinical Research
Nov 9, 2021

Relative Bioavailability Trial in London (FOR-6219 capsule formulation, FOR-6219 tablet formulation)

Completed
  • Relative Bioavailability
  • FOR-6219 capsule formulation
  • FOR-6219 tablet formulation
  • London, United Kingdom
    Richmond Pharmacology Ltd.
Jan 28, 2021

Relative Bioavailability Trial in Baltimore (BDA MDI 160/180 mcg, Pulmicort Flexhaler 180 mcg)

Completed
  • Relative Bioavailability
  • BDA MDI 160/180 mcg
  • Pulmicort Flexhaler 180 mcg
  • Baltimore, Maryland
    Research Site
Sep 28, 2019

Relative Bioavailability Trial in Shanghai (Sulfatinib T capsule, Sulfatinib R capsule)

Completed
  • Relative Bioavailability
  • Sulfatinib T capsule
  • Sulfatinib R capsule
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Nov 8, 2018

Relative Bioavailability Trial in Seoul (Eutropin 4IU, Eutropin AQ 12IU, Eutropin Pen 36IU)

Unknown status
  • Relative Bioavailability
  • Eutropin 4IU, Eutropin AQ 12IU, Eutropin Pen 36IU
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 18, 2017

Relative Bioavailability, AUC, Cmax Trial in Baltimore (D1400147, D14000136, D14000137)

Completed
  • Relative Bioavailability
  • +3 more
  • Baltimore, Maryland
    Research Site
Mar 21, 2017

Relative Bioavailability Trial in Nottingham (ABT-333)

Completed
  • Relative Bioavailability
  • Nottingham, United Kingdom
    Site Reference ID/Investigator# 118435
Jan 30, 2014

Healthy Subjects, Castration Resistant Prostate Cancer (CRPC), Relative Bioavailability Trial in Berlin (MDV3100)

Completed
  • Healthy Subjects
  • +3 more
  • Berlin, Germany
    Parexel International GmbH
Jul 26, 2013